Benzinga - Thu, 08 Apr 2021 16:49:44 -0400
Benzinga - Tue, 30 Mar 2021 04:04:11 -0400
Benzinga - Tue, 23 Mar 2021 13:05:42 -0400
Benzinga - Thu, 11 Feb 2021 12:16:41 -0400
Benzinga - Thu, 04 Feb 2021 12:08:48 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Atea Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The company's medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-25
REV
Q4 2020Est.ActualSurprise
EPS0.1600.950 0.7900
REV45.000M48.633M3.633M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AVIRAtea Pharmaceuticals-0.49%4.7B

Atea Pharmaceuticals Company Questions & Answers

Q

How do I buy Atea Pharmaceuticals (AVIR) stock?

A

You can purchase shares of Atea Pharmaceuticals (NASDAQ: AVIR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Atea Pharmaceuticals's (AVIR) main competitors?

A

Other companies in Atea Pharmaceuticals’s space includes: Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ) and Merck & Co (NYSE:MRK).

Q

What is the target price for Atea Pharmaceuticals?

A

The latest price target for Atea Pharmaceuticals (NASDAQ: AVIR) was reported by Morgan Stanley on 2021-04-06. The analyst firm set a price target for 82.00 expecting AVIR to rise to within 12 months (a possible 45.11% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is Atea Pharmaceuticals (AVIR) stock ?

A

The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $56.51 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Atea Pharmaceuticals (AVIR) dividend?

A

There are no upcoming dividends for Atea Pharmaceuticals.

Q

When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?

A
Atea Pharmaceuticals’s Q1 earnings are confirmed from now on May 25, 2021.
Q

When is the upcoming split for AVIR?

A

There is no upcoming split for Atea Pharmaceuticals.